- 16 May 2022
Union health minister Dr. Harshvardhan on Sunday said that India may start clinical trials of 4 out of 14 COVID-19 vaccine candidates in next 3-5 months. He said that these vaccines are in pre-trial stage right now. These 14 vaccine candidates are among more than hundred vaccine candidate globally.
Dr. Harshvardhan was interacting with BJP spokesperson GVL Narasimha Rao. He said that whole world is working towards development of vaccine to stop the pandemic crisis and WHO is coordinating the efforts. He added that "India is also actively contributing to that effort. We have 14 vaccine candidates that are working on different levels. "Out of these 14, four vaccine candidates, in the next three-five months, may enter the clinical trial stage. Right now, they are in the pre-clinical trial phase," the minister said.
इस दौरान मैंने कहा कि PM श्री @narendramodi जी देशवासियों के स्वास्थ्य को लेकर बहुत संवेदनशील हैं।— Dr Harsh Vardhan (@drharshvardhan) May 24, 2020
उन्होंने #COVID19 संकट को अवसर के रूप में बदलने के लिए 20 लाख करोड़ रुपए के #AatmaNirbharBharat पैकेज की घोषणा कर देश के हर क्षेत्र को आर्थिक मजबूती देने का अद्भुत काम किया है। pic.twitter.com/lu29nXPvxw
The Health Minister also mentioned the contribution of Industry and academic world to vaccine development and said that Ministry of Science is helping the Department of Biotechnology in their efforts. The Department of Biotechnology is the central coordinating agency to identify pathways of vaccine development.
He said that financial support and regulatory clearance will be provided to those who are working on vaccine development. He further added that "It is very difficult to predict when a vaccine will come, but as a doctor, I can say that the process it involves, one year would be a modest estimate". He emphasized on the importance of social vaccines such as masks and social distancing until the vaccine is developed.
It is worth notable that the Centre and private firms have stepped up efforts to develop a vaccine to stop the spread of the COVID-19 pandemic as PMO has said that COVID-19 vaccine was the most pressing need. The PM CARES Fund Trust has allocated ₹100 crore for efforts to develop a COVID-19 vaccine.